VOYA Investment Management
AKBA icon

VOYA Investment Management’s Akebia Therapeutics AKBA Stock Holding History

VOYA Investment Management’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61.7K Sell
44,403
-1,752
-4% -$2.41K ﹤0.01% 2255
2025
Q4 		$74.3K Hold
46,155
– – ﹤0.01% 2301
2025
Q3 		$126K Sell
46,155
-22,852
-33% -$76K ﹤0.01% 2264
2025
Q2 		$251K Buy
69,007
+12,397
+22% +$34.1K ﹤0.01% 2233
2025
Q1 		$109K Sell
56,610
-7,232
-11% -$14.8K ﹤0.01% 2421
2024
Q4 		$121K Sell
63,842
-6,519
-9% -$11.3K ﹤0.01% 2533
2024
Q3 		$92.9K Sell
70,361
-1,336
-2% -$1.78K ﹤0.01% 2680
2024
Q2 		$73.1K Buy
+71,697
New +$88.6K ﹤0.01% 2740
2022
Q3 		– Sell
-301,740
Closed -$107K – 2941
2022
Q2 		$107K Buy
301,740
+176,561
+141% +$74.1K ﹤0.01% 2596
2022
Q1 		$90K Buy
125,179
+26
+0% +$56 ﹤0.01% 2524
2021
Q4 		$283K Buy
125,153
+9,824
+9% +$26.8K ﹤0.01% 2334
2021
Q3 		$332K Buy
115,329
+8,750
+8% +$25K ﹤0.01% 2283
2021
Q2 		$403K Sell
106,579
-2,754
-3% -$9.27K ﹤0.01% 2214
2021
Q1 		$370K Buy
109,333
+11,759
+12% +$42.4K ﹤0.01% 2192
2020
Q4 		$273K Buy
97,574
+12,757
+15% +$37.2K ﹤0.01% 2244
2020
Q3 		$213K Buy
84,817
+39,483
+87% +$346K ﹤0.01% 2122
2020
Q2 		$616K Sell
45,334
-13,176
-23% -$136K ﹤0.01% 1524
2020
Q1 		$444K Buy
58,510
+1,699
+3% +$13.2K ﹤0.01% 1684
2019
Q4 		$359K Buy
56,811
+13,585
+31% +$64.6K ﹤0.01% 2080
2019
Q3 		$169K Hold
43,226
– – ﹤0.01% 2289
2019
Q2 		$209K Buy
43,226
+7,766
+22% +$44.2K ﹤0.01% 2280
2019
Q1 		$290K Sell
35,460
-1,966
-5% -$13.5K ﹤0.01% 2071
2018
Q4 		$207K Buy
37,426
+16,391
+78% +$128K ﹤0.01% 2206
2018
Q3 		$186K Hold
21,035
– – ﹤0.01% 2356
2018
Q2 		$210K Buy
21,035
+727
+4% +$7.28K ﹤0.01% 2336
2018
Q1 		$194K Hold
20,308
– – ﹤0.01% 2328
2017
Q4 		$302K Hold
20,308
– – ﹤0.01% 2134
2017
Q3 		$399K Buy
20,308
+1,854
+10% +$28.5K ﹤0.01% 2001
2017
Q2 		$265K Buy
18,454
+1,933
+12% +$24.5K ﹤0.01% 2245
2017
Q1 		$152K Hold
16,521
– – ﹤0.01% 2364
2016
Q4 		$172K Hold
16,521
– – ﹤0.01% 2339
2016
Q3 		$150 Hold
16,521
– – ﹤0.01% 2393
2016
Q2 		$124K Buy
16,521
+3,830
+30% +$33.4K ﹤0.01% 2429
2016
Q1 		$114K Hold
12,691
– – ﹤0.01% 2372
2015
Q4 		$164K Hold
12,691
– – ﹤0.01% 2359
2015
Q3 		$123K Hold
12,691
– – ﹤0.01% 2439
2015
Q2 		$131K Buy
+12,691
New +$108K ﹤0.01% 2591

Other funds holding AKBA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VOYA Investment Management's AKBA Position: Q1 2026 in Review

VOYA Investment Management reduced its Akebia Therapeutics (AKBA) stake by 3.8% in Q1 2026, selling an estimated $2.41K and leaving 44,403 shares worth $61.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2255.

VOYA Investment Management first reported a position in AKBA in Q2 2015 and has held it in 37 quarters since. The position peaked at $616K in Q2 2020. 171 funds tracked by Wall St. Rank hold AKBA as of Q1 2026.

  • VOYA Investment Management held 44,403 shares of Akebia Therapeutics worth $61.7K as of Q1 2026.
  • VOYA Investment Management sold 1,752 Akebia Therapeutics shares in Q1 2026, an estimated $2.41K.
  • Akebia Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2255 holding.
  • VOYA Investment Management first reported a position in Akebia Therapeutics in Q2 2015 and has held it in 37 quarters since.
  • VOYA Investment Management's Akebia Therapeutics position peaked at $616K in Q2 2020.
  • 171 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.